Dr. Scott Tagawa presented ProstACT GLOBAL, a phase III study of best SOC with or without 177 Lu-DOTA-rosopatamab (TLX591) for patients with PSMA-expressing mCRPC who experienced disease progression ...
Higher MTX-PG concentrations were associated with improved disease activity among patients with RA receiving MTX therapy, though they were also linked to hepatotoxicity.
Severe vivax malaria, once considered a relatively benign infection compared to its counterpart P. falciparum, has emerged as a significant health concern with severe and life-threatening ...